Details of Disease

General Information of Disease (ID: DISJPHK7)

• Disease Name: Glabellar frown line
• Disease Class: NA00-NA0Z: Head injury
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISJPHK7: Glabellar frown line
• ICD Code: ICD-11: ICD-11: NA0Z

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 2 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
DaxibotulinumtoxinA	DMLWYYG	Approved	NA	[1]
PrabotulinumtoxinA	DM9JU0N	Approved	NA	[2]

This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
LetibotulinumtoxinA	DMVSHFO	Phase 3	NA	[3]
EB-001A	DMURTXN	Phase 2	NA	[3]

This Disease is Treated as An Indication in 1 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
DWP-450	DMC93YI	Application submitted	NA	[3]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761127.
• [2] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
• [3] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)